Gut liver brain axis in diseases: the implications for therapeutic interventions
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Gut liver brain axis in diseases: the implications for therapeutic interventions ; volume:8 ; number:1 ; day:6 ; month:12 ; year:2023 ; pages:1-26 ; date:12.2023
Signal transduction and targeted therapy ; 8, Heft 1 (6.12.2023), 1-26, 12.2023
- Klassifikation
-
Medizin, Gesundheit
- Urheber
-
Yan, Mengyao
Man, Shuli
Sun, Benyue
Ma, Long
Guo, Lanping
Huang, Luqi
Gao, Wenyuan
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41392-023-01673-4
- URN
-
urn:nbn:de:101:1-2024022214130248649620
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:45 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Yan, Mengyao
- Man, Shuli
- Sun, Benyue
- Ma, Long
- Guo, Lanping
- Huang, Luqi
- Gao, Wenyuan
- SpringerLink (Online service)
Ähnliche Objekte (12)
GAS6/TAM Axis as Therapeutic Target in Liver Diseases
The gut-liver axis in hepatobiliary diseases
Neutrophils in liver diseases: pathogenesis and therapeutic targets
Immunological mechanisms and therapeutic targets of fatty liver diseases
Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases
The gut–liver axis in sepsis: interaction mechanisms and therapeutic potential
Dietary Interventions in Liver Diseases: Focus on MAFLD and Cirrhosis
Liver-derived human mesenchymal stem cells: a novel therapeutic source for liver diseases
Molecular and Cellular Mediators of the Gut-Liver Axis in the Progression of Liver Diseases
Innate lymphocytes: pathogenesis and therapeutic targets of liver diseases and cancer
Therapeutic Targeting of Hepatic Macrophages for the Treatment of Liver Diseases
The airway neuro-immune axis as a therapeutic target in allergic airway diseases
GAS6/TAM Axis as Therapeutic Target in Liver Diseases
The gut-liver axis in hepatobiliary diseases
Neutrophils in liver diseases: pathogenesis and therapeutic targets
Immunological mechanisms and therapeutic targets of fatty liver diseases
Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases
The gut–liver axis in sepsis: interaction mechanisms and therapeutic potential
Dietary Interventions in Liver Diseases: Focus on MAFLD and Cirrhosis
Liver-derived human mesenchymal stem cells: a novel therapeutic source for liver diseases
Molecular and Cellular Mediators of the Gut-Liver Axis in the Progression of Liver Diseases
Innate lymphocytes: pathogenesis and therapeutic targets of liver diseases and cancer
Therapeutic Targeting of Hepatic Macrophages for the Treatment of Liver Diseases
The airway neuro-immune axis as a therapeutic target in allergic airway diseases
GAS6/TAM Axis as Therapeutic Target in Liver Diseases
The gut-liver axis in hepatobiliary diseases
Neutrophils in liver diseases: pathogenesis and therapeutic targets
Immunological mechanisms and therapeutic targets of fatty liver diseases
Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases
The gut–liver axis in sepsis: interaction mechanisms and therapeutic potential
Dietary Interventions in Liver Diseases: Focus on MAFLD and Cirrhosis
Liver-derived human mesenchymal stem cells: a novel therapeutic source for liver diseases
Molecular and Cellular Mediators of the Gut-Liver Axis in the Progression of Liver Diseases
Innate lymphocytes: pathogenesis and therapeutic targets of liver diseases and cancer
Therapeutic Targeting of Hepatic Macrophages for the Treatment of Liver Diseases